ReP USP - Resultado da busca

Filtros : "Begnami, Maria D" Limpar

Filtros

Artigo de periodico
GLUT1 expression in malignant tumors and its use as an immunodiagnostic marker (2011)
Carvalho, Kátia C; Cunha, Isabela W; Rocha, Rafael M; Ayala, Fernanda R; Cajaíba, Mariana M; Begnami, Maria D; Vilela, Rafael S; Paiva, Geise R; Andrade, Rodrigo G; Soares, Fernando Augusto
Source: Clinics. Unidade: FO
Subjects: IMUNOHISTOQUÍMICA, PROTEÍNAS, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Kátia C et al. GLUT1 expression in malignant tumors and its use as an immunodiagnostic marker. Clinics, v. 66, n. 6, p. 965-972, 2011Tradução . . Disponível em: https://doi.org/10.1590/s1807-59322011000600008. Acesso em: 21 maio 2024.
APA
Carvalho, K. C., Cunha, I. W., Rocha, R. M., Ayala, F. R., Cajaíba, M. M., Begnami, M. D., et al. (2011). GLUT1 expression in malignant tumors and its use as an immunodiagnostic marker. Clinics, 66( 6), 965-972. doi:10.1590/s1807-59322011000600008
NLM
Carvalho KC, Cunha IW, Rocha RM, Ayala FR, Cajaíba MM, Begnami MD, Vilela RS, Paiva GR, Andrade RG, Soares FA. GLUT1 expression in malignant tumors and its use as an immunodiagnostic marker [Internet]. Clinics. 2011 ; 66( 6): 965-972.[citado 2024 maio 21 ] Available from: https://doi.org/10.1590/s1807-59322011000600008
Vancouver
Carvalho KC, Cunha IW, Rocha RM, Ayala FR, Cajaíba MM, Begnami MD, Vilela RS, Paiva GR, Andrade RG, Soares FA. GLUT1 expression in malignant tumors and its use as an immunodiagnostic marker [Internet]. Clinics. 2011 ; 66( 6): 965-972.[citado 2024 maio 21 ] Available from: https://doi.org/10.1590/s1807-59322011000600008
Artigo de periodico
Prognostic Implications of Altered Human Epidermal Growth Factor Receptors (HERs) in Gastric Carcinomas: HER2 and HER3 Are Predictors of Poor Outcome (2011)
Begnami, Maria D; Fukuda, Emy; Fregnani, José H. T. G; Nonogaki, Suely; Montagnini, André L; Costa Júnior, Wilson L. da; Soares, Fernando Augusto
Source: Journal of Clinical Oncology. Unidade: FO
Subjects: CARCINOMA, TRATO DIGESTIVO DE ANIMAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BEGNAMI, Maria D et al. Prognostic Implications of Altered Human Epidermal Growth Factor Receptors (HERs) in Gastric Carcinomas: HER2 and HER3 Are Predictors of Poor Outcome. Journal of Clinical Oncology, v. 29, n. 22, p. 3030-3036, 2011Tradução . . Disponível em: https://doi.org/10.1200/jco.2010.33.6313. Acesso em: 21 maio 2024.
APA
Begnami, M. D., Fukuda, E., Fregnani, J. H. T. G., Nonogaki, S., Montagnini, A. L., Costa Júnior, W. L. da, & Soares, F. A. (2011). Prognostic Implications of Altered Human Epidermal Growth Factor Receptors (HERs) in Gastric Carcinomas: HER2 and HER3 Are Predictors of Poor Outcome. Journal of Clinical Oncology, 29( 22), 3030-3036. doi:10.1200/jco.2010.33.6313
NLM
Begnami MD, Fukuda E, Fregnani JHTG, Nonogaki S, Montagnini AL, Costa Júnior WL da, Soares FA. Prognostic Implications of Altered Human Epidermal Growth Factor Receptors (HERs) in Gastric Carcinomas: HER2 and HER3 Are Predictors of Poor Outcome [Internet]. Journal of Clinical Oncology. 2011 ; 29( 22): 3030-3036.[citado 2024 maio 21 ] Available from: https://doi.org/10.1200/jco.2010.33.6313
Vancouver
Begnami MD, Fukuda E, Fregnani JHTG, Nonogaki S, Montagnini AL, Costa Júnior WL da, Soares FA. Prognostic Implications of Altered Human Epidermal Growth Factor Receptors (HERs) in Gastric Carcinomas: HER2 and HER3 Are Predictors of Poor Outcome [Internet]. Journal of Clinical Oncology. 2011 ; 29( 22): 3030-3036.[citado 2024 maio 21 ] Available from: https://doi.org/10.1200/jco.2010.33.6313

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024